About


This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Johns Hopkins University, Qiagen, Maryland Technology Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.


We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on Advancing Science and Accelerating Innovation.

2017 Agenda

2018 - Under Development

8:30 AM: ARRIVAL

Registration, Breakfast, Networking

9:30 AM: WELCOMING REMARKS

Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami HowieCEO, Maryland Tech Council

9:55 AM: Summary of 2016 & Review of Accomplishments

John Trainer, Vice President, Head of Partnering & Strategy, MedImmune

10:15 AM: KEYNOTE: Governor’s Remarks

Governor Larry HoganGovernor, State of Maryland

10:40 AM: KEYNOTE: Innovation Saves

James C. Greenwood, President & CEO, Biotechnology Innovation Organization

11:00 AM: FIRESIDE CHAT: Building Our Region’s Future

MODERATOR: James C. Greenwood, President & CEO, Biotechnology Innovation Organization

PANELISTS:

Christopher P. Austin, MDDirector, National Center for Advancing Translational Sciences, National Institutes of Health
Joel MarcusFounder & CEO, Alexandria Real Estate
Congressman John K. DelaneyU.S. Representative, Maryland’s 6th District

12:00 PM: LUNCH

Featuring Round Table Sessions with foundations:
WomenHeart
Ovarian Cancer Research Fund Alliance
Allergy & Asthma Network
Focused Ultrasound Foundations

1:00 PM: ADVANCING SCIENCE: We Are Not Alone:  Understanding the Microbiome in Health and Disease

It is widely known that we humans are not exclusively composed of human cells; rather, we also contain a microbiome composed of millions of bacteria, viruses and fungi.  These micro-organisms are not merely passive passengers; they have co-evolved with us impact our human health.  This panel discussion will  explore the current state, future directions and exciting promise of research into the complex ecosystem known as the human microbiome. 

MODERATOR: JoAnn A. Suzich, PhD, Vice President, Research, Infectious Diseases, MedImmune

PANELISTS:

Gregory A. Buck, PhD, Professor, Microbiology and Immunology, Virginia Commonwealth University
Jaques Ravel, Professor, Microbiology and Immunology, Institute for Genome Sciences, University of Maryland School of Medicine
Gabriela Riscuta, MD, Program Director, Nutritional Science Research Group, National Cancer Institute, National Institutes of Health

1:00 PM: ACCELERATING INNOVATION: Biomanufacturing: Innovation and The Future

Innovation and new technology continue to transform biomanufacturing.  Come hear our esteem panelists describe how current advances in production cell lines and manufacturing platforms will continue to shape the future of biologics—all encompassing—from therapeutic proteins, viral vectors and vaccines to organoids.

 

MODERATOR: Marco Chacón, PhD, Assistant Vice President, Industry Alliances, University of Maryland, Baltimore

PANELISTS:

Nicole Faust, PhD, Chief Scientific Officer, CEVEC Pharmaceuticals GmbH
Timothy J. Hahn, PhDSenior Vice President, Global Manufacturing, Novavax
W. James Jackson, PhDSenior Vice President & Chief Scientific Officer, Emergent BioSolutions
Mindy Goldsborough, PhDChief Science & Technology Officer, ATCC

2:00 PM: BREAK: Return to Main Session

2:10 PM: PANEL: University Leaders’ Perspectives on Engaging Industry…

As interactions between universities and industry continue to evolve and expand, the rules of engagement have to accordingly change.  In this panel, higher education leaders will discuss the importance of these partnerships and help us understand how each of their universities form innovative collaborations with industry. 

MODERATOR: William E. “Brit” Kirwan, Chancellor Emeritus, University System of Maryland

PANELISTS:

Ronald Daniels, President, Johns Hopkins University
Robert Caret, Chancellor, University System of Maryland
Richard P. Shannon, MDExecutive Vice President, Health Affairs, University of Virginia
Pamela B. Davis, MD, PhDDean, School of Medicine and Senior VP for Medical Affairs, Case Western Reserve University
Christine Gulbranson, PhD, MBASenior Vice President, Innovation & Entrepreneurship, University of California, Office of the President

3:10 PM: Networking Break

3:40 PM: PANEL:  …And the Industry Perspective

As interactions between industry and university continue to evolve and expand, the rules of engagement have to accordingly change.  A panel of industry experts will speak to the need for working with universities and new models for success in academic partnering. 

MODERATOR: William E. “Brit” Kirwan, Chancellor Emeritus, University System of Maryland

PANELISTS:

Anthony Coyle, PhD, Senior Vice President & Chief Scientific Officer, Pfizer, Centers for Therapeutic Innovation
Sharon Semones, Advisor, External Innovation, Eli Lilly and Company
Shaun Grady, Vice President, Business Development Operations, AstraZeneca
Sunita Malhotra, PhDSenior Manager, Search & Evaluation, AbbVie
Bethany MancillaVice President, Business Development, Amgen

4:40 PM: PANEL: Many Initiatives…One Goal: Growing the BioHealth Capital Region

Latest initiatives from groups impacting the BioHealth Capital Region.

PANELISTS:

Rich BendisPresident & CEO, BioHealth Innovation Inc.
Daniel Abdun-NabiPresident & CEO, Emergent Biosolutions
Amarnath Bhat, PhDVice President, Open Health Systems Laboratory, Inc.
Douglas GoldsteinAVP, Business Development, and Innovation Officer, Inova
County Executive Isiah “Ike” LeggettCounty Executive, Montgomery County
Jason S. MillerChief Executive Officer, Greater Washington Partnership

5:20 PM: DAY ONE CLOSING REMARKS

Doug DoerflerPresident & CEO, MaxCyte

5:30 PM: GENERAL RECEPTION

During our General Reception, guests of the Forum are invited to join us for a tour of MdBio’s Mobile eXploration Lab (MXLab), the country’s largest, most advanced mobile laboratory. The lab has been custom-designed to expand new technology and laboratory science experiences and pique students’ interests in STEM learning and careers. Expandable to nearly 1,000 square feet of interior space, the lab can accommodate more than 40 students.

The MXLab will be parked at the main entrance of the MedImmune building, and open to registered attendees of the BioHealth Capital Region Forum starting at 5:30pm.

8:00 AM: ARRIVAL

Breakfast & Networking
Women in Bio

SPEAKER: Sherri-Gae Scott, PhDSponsorship Vice Chair, Women in Bio

8:30 AM: WELCOMING REMARKS

Bahija JallalExecutive Vice President, AstraZeneca, and Head, MedImmune

8:40 AM: KEYNOTE: A Conversation with Senator Van Hollen

HOSTED BY: Mark Walsh, Former Head of Innovation and Investment, U.S. Small Business Administration

SPEAKER:
Senator Chris Van HollenUnited States Senator for the State of Maryland

9:10 AM: BREAK: Move to Tracks

9:20 AM: ADVANCING SCIENCE: Government Funding: Role in Building the Scientific Ecosystem

Government has played a key role in advancing research and innovation for the American scientific ecosystem but cuts in federal funding are threatening to slow the pace of progress. As the research funding climate changes, it is important explore government’s evolving role and how it can further advance innovation through partnerships and other channels. This panel will engage leading experts to discuss government’s current role and how changes can be made to maintain the country’s position as a leader in innovation.

MODERATOR: Beth Meagher, Principal and Leader, Federal Strategy and Translational Medicine Practices, Deloitte Consulting LLC

PANELISTS:
Col. Wanda SalzerDirector, Congressionally Directed Medical Research Programs
Justin C. Sanchez, PhD, Director, Biological Technologies Office, DARPA
Jesus Soriano, MD, PhD, Program Director, SBIR/STTR, National Science Foundation

9:20 AM: ACCELERATING INNOVATION: Raising Venture Capital Financing:  How to Succeed Bigly (Big League)

Many start-up companies particularly in the BioHealth Capital Region are very good at securing non-dilutive financing.  Our experienced group of panelists will talk about how to crack the code to break in to the Venture Capital and secure the first institutional round. 

 

 

MODERATOR: Samuel Wu, MD, PhD, Managing Director, Acuris Partners

PANELISTS:

Sara Nayeem, MDPartner, New Enterprise Associates
Rick Kohr, CEO, Evergreen Advisors LLC
Hooks JohnstonManaging Director, Inova Strategic Investments
Kristen KosofskySenior Managing Director, Hercules Capital

10:20 AM: Networking Break

10:50 AM: ADVANCING SCIENCE: Convergence: Blurring the Boundaries of Scientific Disciplines

The future of developing new cures for patients is headed towards personalized treatment.  To achieve the personalization of medicine, it is important that the convergence of multiple fields of science come together and strategize to develop new treatments.  The panelists will discuss their experiences and how each of their approaches to working at the nexus of multiple disciplines helps move the needle forward in developing cures. 

MODERATOR: Martin RosendaleCEO, Selnova, LLC

PANELISTS:

William E. Bentley, Robert E. Fischell Distinguished Chair in Engineering, University of Maryland
Praduman Jain, Founder & CEO, Vibrent Health
Kevin McRaith, CEO, WellDoc, Inc.
Jared Josleyn, Partnerships & Business Development Lead, Verily Life Sciences

10:50 AM: ACCELERATING INNOVATION: A Call to Action: Developing the Talent Pipeline

As we grow the region there is an acute need to build the talent pipeline.  Hear from government, industry and academia representatives as to how they each address this issue.  They will speak to new models and discuss best practices for collaboratively achieving the goal of educating, training and hiring our talent pool.

 

MODERATOR: Wendy Penry, SHRM-SCP, Chief Human Resource Officer, Aeras

PANELISTS:

Kelly M. Schulz, Secretary Of Labor, Licensing & Regulation, State of Maryland
Dr. Sanjay Rai, Senior Vice President for Academic Affairs, Montgomery College
Scott Ralls, PhD, President, Northern Virginia Community College
Chris FrewVice President, Breezio and Executive Director, BioBuzz Workforce Foundation

12:00 PM: LUNCH

Introduction to MCEDC

David Petr, President and CEO, Montgomery County Economic Development Corporation

1:00 PM: KEYNOTE: Personalized Medicine Initiative

Eric DishmanDirector, All Of Us Research Program, National Institutes of Health

1:30 PM: BREAK – Move to Tracks

1:40 PM: ADVANCING SCIENCE: The Journey of Immunotherapy: From Idea to Patient

Our diverse group of panelists will each describe their role in getting an idea transformed into a drug that can potentially treat human disease.  They will speak to the challenges at each stage as well as paradigms they had to develop to keep moving to the next juncture. 

MODERATOR: Ashok Gupta, MD, PhDVice President, Immuno-Oncology Clinical Development, MedImmune

PANELISTS:

James L. Gulley, MD, PhD, Chief, Genitourinary Malignancies Branch & Director, Medical Oncology Service, CCR National Cancer Institute, National Institutes of Health
Matthew Mulvey, CEO, BeneVir
Thomas P. Loughran, Jr., MD, Director, University of Virginia Cancer Center
Bill Hearl, PhDCEO, Immunomic Therapeutics, Inc.
Frank Weichold, MD, PhDDirector, Critical Path and Regulatory Science Initiatives, U.S. Food and Drug Administration

1:40 PM: ACCELERATING INNOVATION: Fostering Innovation Led Economic Development

Economic Development in the BioHealth Capital Region is inextricably tied to the support of its universities. Our panelists will speak to the role of universities, best practices and public private partnerships that are helping drive innovation and regional growth. 

MODERATOR: Tom Sadowski, Vice Chancellor for Economic Development, University System of Maryland

PANELISTS:

John M. Wasilisin, President & COO, TEDCO
Ed Albrigo, President & CEO, Center for Innovative Technology
Dr. Gerald L. Gordon, President & CEO, Fairfax County Economic Development Authority
Christy WyskielSenior Advisor to the President & Head of Technology Ventures, Johns Hopkins University

2:40 PM: BREAK: Return to Main Session

2:50 PM: PLENARY: Putting the Puzzle Pieces Together

MODERATORS:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. GallagherCEO, Virginia Bio

PANELISTS:
Ripley Ballou, MD, Vice President & Head of US R&D, Vaccines, GSK
Donald L. Trump, CEO & Executive Director, Inova Schar Cancer Institute
Douglas Liu, Senior Vice President, Global Operations, Qiagen
Jarrod BorkatSenior Director, Partnering & Strategy, MedImmune

3:40 PM: Oncology Innovation Initiatives

SPEAKERS:

Rosemarie TrumanFounder & CEO, The Center for Advancing Innovation
Bill Hearl, PhDCEO, Immunomic Therapeutics, Inc.

3:50 PM: CRAB TRAP

Be sure to stay and watch the five finalists present in front of a panel of prominent industry funding experts and executives for a chance to win the Grand Prize.

MODERATOR: Rich Bendis, President & CEO, BioHealth Innovation Inc

JUDGES:

Jared JoselynPartnerships & Business Development Lead, Verily Life Sciences
Bob SilvermanHead, Externalized Drug Discovery Partnering, Roche
Peter JobseManaging Director, Inova Strategic Investments
Jason Fuller, PhDPrincipal, Washington, DC, New Enterprise Associates 
Shaun GradyVice President, Business Development Operations, AstraZeneca
Paul Silber, PhDFounding Principal, Blu Venture Investors

5:00 PM: CLOSING OF MEETING

2017 Selected Speakers

2018 - Under Development

Daniel J. Abdun-Nabi

Daniel J. Abdun-Nabi

President & CEO, Emergent BioSolutions

Ed Albrigo

Ed Albrigo

President and CEO, Center for Innovative Technology

Christopher P. Austin, MD

Christopher P. Austin, MD

Director, National Center for Advancing Translational Sciences, National Institutes of Health

Ripley Ballou, MD

Ripley Ballou, MD

Vice President & Head of US R&D, Vaccines, GSK

Rich Bendis

Rich Bendis

President and CEO of BioHealth Innovation Inc.

William E. Bentley

William E. Bentley

Robert E. Fishcell Distinguished Chair in Engineering, University of Maryland

Amarnath Bhat, PhD

Amarnath Bhat, PhD

Vice President, Open Health Systems Laboratory, Inc.

Jarrod Borkat

Jarrod Borkat

Senior Director, External Partnerships & Collaborations, MedImmune

Gregory A. Buck, PhD

Gregory A. Buck, PhD

Professor, Microbiology and Immunology, Virginia Commonwealth University

Robert Caret

Robert Caret

Chancellor, University System of Maryland

Marco Chacón, PhD

Marco Chacón, PhD

Assistant Vice President, Industry Alliances, University of Maryland, Baltimore

Anthony Coyle, PhD

Anthony Coyle, PhD

Senior Vice President & Chief Scientific Officer, Centers for Therapeutic Innovation, Pfizer

Ronald Daniels

Ronald Daniels

President, Johns Hopkins University

Pamela B. Davis, MD, PhD

Pamela B. Davis, MD, PhD

Dean, School of Medicine and Senior Vice President for Medical Affairs, Case Western Reserve University

Congressman John K. Delaney

Congressman John K. Delaney

United States Representative, Maryland's 6th District

Eric Dishman

Eric Dishman

Director, All Of Us Research Program, National Institutes of Health

Douglas Doerfler

Douglas Doerfler

President & CEO, MaxCyte, Inc.

Dr. Nicole Faust

Dr. Nicole Faust

Chief Scientific Officer at CEVEC Pharmaceuticals

Chris Frew

Chris Frew

Vice President, Breezio and Executive Director, BioBuzz Workforce Foundation

Jason Fuller, PhD

Jason Fuller, PhD

Principal, Washington, DC, New Enterprise Associates

Jeffrey M. Gallagher

Jeffrey M. Gallagher

CEO, Virginia Bio

Mindy Goldsborough, PhD

Mindy Goldsborough, PhD

Chief Science & Technology Officer, ATCC

Douglas Goldstein

Douglas Goldstein

AVP, Business Development, and Innovation Officer, Inova

Dr. Gerald L. Gordon

Dr. Gerald L. Gordon

President and CEO of the Economic Development Authority in Fairfax County, Virginia

Shaun Grady

Shaun Grady

Vice President, Business Development Operations, AstraZeneca

James C. Greenwood

James C. Greenwood

President & CEO, Biotechnology Innovation Organization

Christine Gulbranson, PhD, MBA

Christine Gulbranson, PhD, MBA

Senior Vice President, Innovation & Entrepreneurship, University of California, Office of the President

James L. Gulley, MD, PhD

James L. Gulley, MD, PhD

Chief, Genitourinary Malignancies Branch & Director, Medical Oncology Service, CCR; National Cancer Institute, National Institutes of Health

Ashok Gupta, MD, PhD

Ashok Gupta, MD, PhD

Vice President, Immuno-Oncology Clinical Development, MedImmune

Timothy J. Hahn, PhD

Timothy J. Hahn, PhD

Senior Vice President, Global Manufacturing Operations, Novavax

Bill Hearl, PhD

Bill Hearl, PhD

CEO, Immunomic Therapeutics, Inc.

Governor Larry Hogan

Governor Larry Hogan

Governor, State of Maryland

Tami Howie

Tami Howie

CEO, Maryland Tech Council

W. James Jackson, PhD

W. James Jackson, PhD

Senior Vice President & Chief Scientific Officer, Emergent BioSolutions

Praduman Jain

Praduman Jain

Founder & CEO, Vibrent Health

Bahija Jallal

Bahija Jallal

Executive Vice President, AstraZeneca & Head of MedImmune

Peter Jobse

Peter Jobse

Managing Director, Inova Strategic Investors

Hooks Johnston

Hooks Johnston

Managing Director, Inova Strategic Investments

Jared Josleyn

Jared Josleyn

Partnerships & Business Development Lead, Verily Life Sciences

William E. “Brit” Kirwan

William E. “Brit” Kirwan

Chancellor Emeritus, University System of Maryland

Rick Kohr

Rick Kohr

CEO, Evergreen Advisors LLC

Kristen Kosofsky

Kristen Kosofsky

Senior Managing Director, Hercules Capital

County Executive Isiah “Ike” Leggett

County Executive Isiah “Ike” Leggett

County Executive, Montgomery County, MD

Douglas Liu

Douglas Liu

Senior Vice President, Global Operations, Qiagen

Thomas P. Loughran, Jr., MD

Thomas P. Loughran, Jr., MD

Director, UVA Cancer Center

Sunita Malhotra, PhD

Sunita Malhotra, PhD

Senior Manager, Search & Evaluation, AbbVie

Bethany Mancilla

Bethany Mancilla

Vice President, Business Development, Amgen, Inc.

Joel Marcus

Joel Marcus

Founder & CEO, Alexandria Real Estate

Kevin McRaith

Kevin McRaith

Chief Executive Officer, WellDoc

Beth Meagher

Beth Meagher

Principal and Leader, Federal Strategy and Translational Medicine Practices, Deloitte Consulting LLP

Jason S. Miller

Jason S. Miller

Chief Executive Officer, Greater Washington Partnership

Matthew Mulvey

Matthew Mulvey

CEO, BeneVir

Sara Nayeem, MD

Sara Nayeem, MD

Partner, New Enterprise Associates

Wendy Penry, SHRM-SCP

Wendy Penry, SHRM-SCP

Chief Human Resources Officer, Aeras

David Petr

David Petr

President and CEO, Montgomery County Economic Development Corporation

Sanjay Rai, PhD

Sanjay Rai, PhD

Senior Vice President for Academic Affairs, Montgomery College

Scott Ralls, PhD

Scott Ralls, PhD

President, Northern Virginia Community College

Jacques Ravel

Jacques Ravel

Professor, Microbiology and Immunology, Institute for Genome Sciences, University of Maryland

Gabriela Riscuta, MD

Gabriela Riscuta, MD

Program Director, Nutritional Science Research Group, National Cancer Institute, National Institutes of Health

Martin Rosendale

Martin Rosendale

CEO, Selnova, LLC

Tom Sadowski

Tom Sadowski

Vice Chancellor for Economic Development, University System of Maryland

Wanda Salzer, Col, USAF, MC

Wanda Salzer, Col, USAF, MC

Director, Congressionally Directed Medical Research Programs, USAMRMC

Justin C. Sanchez, PhD

Justin C. Sanchez, PhD

Director, Biological Technologies Office, DARPA

Kelly M. Schulz

Kelly M. Schulz

Secretary, Maryland Department of Labor, Licensing & Regulation

Sharon Semones

Sharon Semones

Advisor, External Innovation, Eli Lilly and Company

Richard P. Shannon, MD

Richard P. Shannon, MD

Executive Vice President, Health Affairs, University of Virginia

Paul Silber, PhD

Paul Silber, PhD

Founding Principal, Blu Venture Investors

Robert Silverman

Robert Silverman

Head, External Drug Discovery, Roche Partnering

Jesus Soriano, MD, PhD

Jesus Soriano, MD, PhD

Program Director, SBIR/STTR, National Science Foundation

JoAnn A. Suzich, PhD

JoAnn A. Suzich, PhD

Vice President, Research, Infectious Diseases, MedImmune

John Trainer

John Trainer

Vice President, Partnering & Strategy, MedImmune

Rosemarie Truman

Rosemarie Truman

Founder & CEO, The Center for Advancing Innovation

Donald L. Trump, MD, FACP

Donald L. Trump, MD, FACP

CEO & Executive Director, Inova Schar Cancer Institute

Senator Chris Van Hollen

Senator Chris Van Hollen

United States Senator, State of Maryland

Mark Walsh

Mark Walsh

Former Head of Innovation and Investment, U.S. Small Business Administration

John M. Wasilisin

John M. Wasilisin

President & COO, TEDCO

Frank F. Weichold, MD, PhD

Frank F. Weichold, MD, PhD

Director, Critical Path and Regulatory Science Initiatives, US Food and Drug Administration

Samuel Wu, MD, PhD

Samuel Wu, MD, PhD

Managing Director, Acuris Partners

Christy Wyskiel

Christy Wyskiel

Senior Advisor to the President & Head of Technology Ventures, Johns Hopkins University

2017 Sponsors

2018 - Under Development

Crab Trap

You thought the Shark Tank was tough… wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for a chance to be named the company with the most commercial potential at the BioHealth Regional Forum.

Deadline for entries is March 25th – Finalists will be announced by April 4th – Regional Biotech Forum Event: Panel Presentation is on April 24th

Submit an Application

crabtrap

Sponsored by:

WSGR-logo_0

Present at the Regional Biotech Forum on April 20, 2017
Five finalists will have a chance to win the grand prize by presenting in
front of a panel of prominent industry funding experts and executives including:

  • Jason Fuller, Principal, New Enterprise Associates (NEA)
  • Shaun Grady, Vice President, Strategic Partnering & Business Development, AstraZeneca
  • Peter Jobse, Managing Director, Inova Strategic Investments/Inova Personalized Health Accelerator
  • Paul Silber, Founding Principal, Blu Venture Investors
  • Jared Josleyn, CLP, Partnerships and Business Development Lead, Verily Life Sciences
  • Robert A. Silverman, Head Externalized Drug Discovery Partnering, Roche

    PRIZES

    Grand Prize
    Grand Prize: $10,000, Incubation Space in Prince William County, VA or Montgomery County, MD, Business Mentoring

    CRITERIA
    Product
    Technical Feasibility
    Marketing/Strategy
    Leadership Team
    Financial/Projection

combined

Register